MiNK Therapeutics Announces 77% Survival Rate in Intubated Patients with COVID-19 Respiratory Failure Treated with AgenT-797

NEXT STORY
Iovance Biotherapeutics Announces Clinical Data for LN-145 in Non-Small Cell Lung Cancer at Society for Immunotherapy of Cancer (SITC) Annual Meeting
PREV STORY
Global $32.67 Billion Bioethanol Yeast Market to 2028: Cleaning & Disinfection Segment Projected to Register the Fastest CAGR Over Forecast Period
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics ...

author_avatar
NASDAQ Market News

DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting

Montrouge, France, May 8, 2018 DBV Technologies to Present New Clinical Data from Viaskin ...

author_avatar
NASDAQ Market News

Telehealth Ventilators Worth More Than RM2 Million to be Donated to Malaysian Hospitals to Treat COVID-19 Patients in Intensive Care

author_avatar
NASDAQ Market News